AstraZeneca CEO doubles down on U.S. amid rumors of listing shift ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
CEO Pascal Soriot
since
auto-detected in 2 stories
7 months ago
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.
AstraZeneca boss ‘wants to shift stock market listing to US’ ○
Report claims CEO Pascal Soriot talked in private about moving UK’s most valuable listed company and considered shifting its domicile
AstraZeneca’s chief executive, Pascal Soriot, has reportedly said …
page 1 of 1